Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple dupuytren contractures

Journal of Hand Surgery

Volumn 39, Issue 1, 2014, Pages 57-64

  Coleman, Stephen ^a,b,c,d,e   Gilpin, David ^a,b,c,d   Kaplan, F Thomas D ^a,b,c,d   Houston, Anthony ^a,b,c,d   Kaufman, Gregory J ^a,b,c,d   Cohen, Brian M ^a,b,c,d   Jones, Nigel ^a,b,c,d   Tursi, James P ^a,b,c,d  

^a Brisbane Hand and Upper Limb Clinic   (Australia)

^b Indiana Hand Center   (United States)

^c Caboolture Clinical Research Centre   (Australia)

^d Auxilium Pharmaceuticals Inc   (United States)

^e Auxilium Pharmaceuticals Inc   (United Kingdom)

Author keywords

Collagenase clostridium histolyticum (CCH); Dupuytren contracture; Dupuytren disease; patient satisfaction; treatment outcome

Indexed keywords

ADRENALIN; BUPIVACAINE; CLOSTRIDIOPEPTIDASE A; LIDOCAINE; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; BLISTER; BLOOD BLISTER; CONTUSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DUPUYTREN CONTRACTURE; ECCHYMOSIS; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE HEMATOMA; INJECTION SITE REACTION; INJECTION SITE SWELLING; INTRAOPERATIVE PERIOD; JOINT CONTRACTURE; LACERATION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PAIN; PATIENT SATISFACTION; PERIPHERAL EDEMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; PULLEY RUPTURE; RANGE OF MOTION; TENDON RECONSTRUCTION; TENDON RUPTURE; WOUND CARE; WOUND HEALING IMPAIRMENT;

COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH); DUPUYTREN CONTRACTURE; DUPUYTREN DISEASE; PATIENT SATISFACTION; TREATMENT OUTCOME;

AGED; DUPUYTREN CONTRACTURE; FEMALE; FINGER JOINT; HUMANS; INJECTIONS, INTRALESIONAL; MALE; METACARPOPHALANGEAL JOINT; MICROBIAL COLLAGENASE; MIDDLE AGED; RANGE OF MOTION, ARTICULAR; RETREATMENT;

EID: 84891587791     PISSN: 03635023     EISSN: 15316564     Source Type: Journal    
DOI: 10.1016/j.jhsa.2013.10.002     Document Type: Article

References (14)

1. G.M. Rayan Dupuytren's disease: anatomy, pathology, presentation, and treatment J Bone Joint Surg Am 89 1 2007 189 198
2. N.E. Picardo, and W.S. Khan Advances in the understanding of the aetiology of Dupuytren's disease Surgeon 10 3 2012 151 158
3. C. Bainbridge, L.B. Dahlin, P.P. Szczypa, J.C. Cappelleri, D. Guerin, and R.A. Gerber Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts Eur Orthop Traumatol 3 1 2012 31 41
4. R.M. McFarlane, and D.A. McGrouther Complications and their management R.M. McFarlane, D.A. McGrouther, M.H. Flint, Dupuytren's Disease 2009 Churchill Livingstone New York 377 382
5. L. Hurst Dupuytren's contracture S.W. Wolfe, R.N. Hotchkiss, W.C. Pederson, J.A. Koziol, Green's Operative Hand Surgery 6th ed. 2011 Churchill Livingstone Philadelphia, PA 141 158
6. L.C. Hurst, M.A. Badalamente, and V.R. Hentz et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture N Engl J Med 361 10 2009 968 979
7. D. Gilpin, S. Coleman, S. Hall, A. Houston, J. Karrasch, and N. Jones Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease J Hand Surg Am 35 12 2010 2027 2038
8. S.S. Desai, and V.R. Hentz Collagenase clostridium histolyticum for Dupuytren's contracture Expert Opin Biol Ther 10 9 2010 1395 1404
9. J. Witthaut, G. Jones, N. Skrepnik, H. Kushner, A. Houston, and T.R. Lindau Efficacy and safety of collagenase clostridium histolyticum, a nonsurgical treatment for adults with Dupuytren's contracture: short-term results from two open-label studies, in the US (JOINT I) and Australia and Europe (JOINT II) J Hand Surg Am 38 1 2013 2 11
10. United States Food and Drug Administration, Center for Drug Evaluation and Research. FDA briefing document for the September 16, 2009 Arthritis Advisory Committee meeting. Xiaflex (AA4500/collagenase clostridium histolyticum) for advanced Dupuytren's disease. http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ ArthritisDrugsAdvisoryCommittee/UCM182013.pdf. Accessed January 25, 2013.
11. Xiaflex (collagenase clostridium histolyticum) [prescribing information] February 2012 Auxilium Pharmaceuticals, Inc. Malvern, PA
12. S. Coleman, D. Gilpin, J. Tursi, G. Kaufman, N. Jones, and B. Cohen Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study BMC Musculoskelet Disord 13 2012 61
13. AUX-CC-859 (CORD II) clinical study report. A phase 3, double-blind, randomized, placebo-controlled study of the safety and efficacy of AA4500 in the treatment of subjects with advanced Dupuytren's disease followed by an open-label extension phase January 27, 2009 Auxilium Pharmaceuticals, Inc. Malvern, PA
14. C.A. Peimer, C.A. McGoldrick, and G.J. Fiore Nonsurgical treatment of Dupuytren's contracture: 1-year US post-marketing safety data for collagenase clostridium histolyticum Hand 7 2012 143 146